{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T17:45:58Z","timestamp":1791654358464,"version":"4.3.4"},"reference-count":49,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T00:00:00Z","timestamp":1664928000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["756\/15, 405\/18, 1708\/20"],"award-info":[{"award-number":["756\/15, 405\/18, 1708\/20"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003975","name":"Israel Cancer Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006245","name":"Ministry of Science and Technology, Israel","doi-asserted-by":"publisher","award":["59077, 59078"],"award-info":[{"award-number":["59077, 59078"]}],"id":[{"id":"10.13039\/501100006245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001698","name":"Israel Cancer Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001698","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000833","name":"Rosetrees Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000833","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>\n                    Neutrophils play critical roles in a broad spectrum of clinical conditions. Accordingly, manipulation of neutrophil function may provide a powerful immunotherapeutic approach. However, due to neutrophils characteristic short half-life and their large population number, this possibility was considered impractical. Here we describe the identification of peptides which specifically bind either murine or human neutrophils. Although the murine and human neutrophil-specific peptides are not cross-reactive, we identified CD177 as the neutrophil-expressed binding partner in both species. Decorating nanoparticles with a neutrophil-specific peptide confers neutrophil specificity and these neutrophil-specific nanoparticles accumulate in sites of inflammation. Significantly, we demonstrate that encapsulating neutrophil modifying small molecules within these nanoparticles yields specific modulation of neutrophil function (ROS production, degranulation, polarization), intracellular signaling and longevity both\n                    <jats:italic>in vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    . Collectively, our findings demonstrate that neutrophil specific targeting may serve as a novel mode of immunotherapy in disease.\n                  <\/jats:p>","DOI":"10.3389\/fimmu.2022.1003871","type":"journal-article","created":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T08:52:05Z","timestamp":1664959925000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":23,"title":["Targeted nanoparticles modify neutrophil function in vivo"],"prefix":"10.3389","volume":"13","author":[{"given":"Sandra","family":"V\u00f6ls","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Kaisar-Iluz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merav E.","family":"Shaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arik","family":"Ryvkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haim","family":"Ashkenazy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avishag","family":"Yehuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronza","family":"Atamneh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adina","family":"Heinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meital","family":"Ben-David-Naim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Menucha","family":"Nadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shira","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Mitesser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth J.","family":"Salpeter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Dzikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zvi","family":"Hayouka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan M.","family":"Gershoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zvi G.","family":"Fridlender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zvi","family":"Granot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20220011","article-title":"Neutrophil phenotypes and functions in cancer: A consensus statement","volume":"219","author":"Quail","year":"2022","journal-title":"J Exp Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.aat4579","article-title":"Neutrophils: New insights and open questions","volume":"3","author":"Ley","year":"2018","journal-title":"Sci Immunol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1160\/TH08-12-0844","article-title":"Novel aspects in the regulation of the leukocyte adhesion cascade","volume":"102","author":"Chavakis","year":"2009","journal-title":"Thromb Haemost"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-1502","article-title":"Plasticity beyond cancer cells and the \u201cimmunosuppressive switch\u201d","volume":"75","author":"Granot","year":"2015","journal-title":"Cancer Res"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-021-00571-6","article-title":"Neutrophils in cancer: heterogeneous and multifaceted","volume":"22","author":"Hedrick","year":"2022","journal-title":"Nat Rev Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.4MIR0220-574RR","article-title":"Neutrophils at the crossroads of innate and adaptive immunity","volume":"108","author":"Rosales","year":"2020","journal-title":"J Leukoc Biol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2019.04.012","article-title":"Neutrophil diversity in health and disease","volume":"40","author":"Silvestre-Roig","year":"2019","journal-title":"Trends Immunol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-020711-074942","article-title":"Neutrophil function: from mechanisms to disease","volume":"30","author":"Amulic","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nri3024","article-title":"Neutrophils in the activation and regulation of innate and adaptive immunity","volume":"11","author":"Mantovani","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"B10","doi-asserted-by":"publisher","first-page":"101582","DOI":"10.1016\/j.smim.2021.101582","article-title":"The dual role of neutrophils in cancer","volume":"57","author":"Shaul","year":"2021","journal-title":"Semin Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-019-0571-2","article-title":"Programmed \u2018disarming\u2019 of the neutrophil proteome reduces the magnitude of inflammation","volume":"21","author":"Adrover","year":"2020","journal-title":"Nat Immunol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1002\/art.41796","article-title":"RNA Externalized by neutrophil extracellular traps promotes inflammatory pathways in endothelial cells","volume":"73","author":"Blanco","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2514","article-title":"The neutrophil in vascular inflammation","volume":"17","author":"Phillipson","year":"2011","journal-title":"Nat Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1172\/JCI124616","article-title":"More friend than foe: the emerging role of neutrophils in tissue repair","volume":"129","author":"Peiseler","year":"2019","journal-title":"J Clin Invest"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1159\/000493101","article-title":"Expanding neutrophil horizons: New concepts in inflammation","volume":"10","author":"Chatfield","year":"2018","journal-title":"J Innate Immun"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1002\/JLB.3RI0917-361R","article-title":"Neutrophil heterogeneity: Bona fide subsets or polarization states","volume":"103","author":"Deniset","year":"2018","journal-title":"J Leukoc Biol"},{"key":"B17","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/s00005-017-0476-4","article-title":"Heterogeneity among neutrophils","volume":"66","author":"Garley","year":"2018","journal-title":"Arch Immunol Ther Exp (Warsz)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2018.00113","article-title":"Neutrophil: A cell with many roles in inflammation or several cell types","volume":"9","author":"Rosales","year":"2018","journal-title":"Front Physiol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2014.12.039","article-title":"Phenotypic diversity and plasticity in circulating neutrophil subpopulations in cancer","volume":"10","author":"Sagiv","year":"2015","journal-title":"Cell Rep"},{"key":"B20","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/s41568-020-0281-y","article-title":"Neutrophil diversity and plasticity in tumour progression and therapy","volume":"20","author":"Jaillon","year":"2020","journal-title":"Nat Rev Cancer"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2009.06.017","article-title":"Polarization of tumor-associated neutrophil phenotype by TGF-beta: \u201cN1\u201d versus \u201cN2\u201d TAN","volume":"16","author":"Fridlender","year":"2009","journal-title":"Cancer Cell"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3390\/jcm5120118","article-title":"The dual role of neutrophils in inflammatory bowel diseases","volume":"5","author":"Wera","year":"2016","journal-title":"J Clin Med"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1016\/j.bj.2020.09.001","article-title":"Understanding the role of neutrophils in acute respiratory distress syndrome","volume":"44","author":"Yang","year":"2021","journal-title":"BioMed J"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1111\/imm.13419","article-title":"Our evolving view of neutrophils in defining the pathology of chronic lung disease","volume":"164","author":"Mincham","year":"2021","journal-title":"Immunology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1038\/s41584-021-00738-4","article-title":"The role of neutrophils in rheumatic disease-associated vascular inflammation","volume":"18","author":"Wang","year":"2022","journal-title":"Nat Rev Rheumatol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01710","article-title":"Neutrophils as a therapeutic target in cancer","volume":"10","author":"Granot","year":"2019","journal-title":"Front Immunol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.866747","article-title":"Targeting neutrophils for promoting the resolution of inflammation","volume":"13","author":"Filep","year":"2022","journal-title":"Front Immunol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"114292","DOI":"10.1016\/j.bcp.2020.114292","article-title":"Targeting neutrophils in asthma: A therapeutic opportunity","volume":"182","author":"De Volder","year":"2020","journal-title":"Biochem Pharmacol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.3390\/pharmaceutics12121222","article-title":"Neutrophils and macrophages as targets for development of nanotherapeutics in inflammatory diseases","volume":"12","author":"Su","year":"2020","journal-title":"Pharmaceutics"},{"key":"B30","doi-asserted-by":"publisher","first-page":"101544","DOI":"10.1016\/j.redox.2020.101544","article-title":"Oxidative stress-based therapeutics in COPD","volume":"33","author":"Barnes","year":"2020","journal-title":"Redox Biol"},{"key":"B31","doi-asserted-by":"publisher","first-page":"21","DOI":"10.3390\/jcm6020021","article-title":"Oxidative stress in COPD: Sources, markers, and potential mechanisms","volume":"6","author":"McGuinness","year":"2017","journal-title":"J Clin Med"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2017.00512","article-title":"Role of proteases in chronic obstructive pulmonary disease","volume":"8","author":"Pandey","year":"2017","journal-title":"Front Pharmacol"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-01-259028","article-title":"In vivo labeling with 2H2O reveals a human neutrophil lifespan of 5","volume":"116","author":"Pillay","year":"2010","journal-title":"4 days Blood"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1093\/nar\/gky077","article-title":"Phage display peptide libraries: deviations from randomness and correctives","volume":"46","author":"Ryvkin","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"B35","doi-asserted-by":"publisher","first-page":"14882","DOI":"10.1038\/s41598-017-14922-8","article-title":"A method for quantifying molecular interactions using stochastic modelling and super-resolution microscopy","volume":"7","author":"Bermudez-Hernandez","year":"2017","journal-title":"Sci Rep"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevTherDrugCarrierSyst.2013006475","article-title":"Poly(lactic-co-glycolic) acid-controlled-release systems: experimental and modeling insights","volume":"30","author":"Hines","year":"2013","journal-title":"Crit Rev Ther Drug Carrier Syst"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M116.741884","article-title":"Identification of neutrophil exocytosis inhibitors (Nexinhibs), small molecule inhibitors of neutrophil exocytosis and inflammation: DRUGGABILITY OF THE SMALL GTPase Rab27a","volume":"291","author":"Johnson","year":"2016","journal-title":"J Biol Chem"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.7b00016","article-title":"Delivery of liposomal quantum dots via monocytes for imaging of inflamed tissue","volume":"11","author":"Aizik","year":"2017","journal-title":"ACS Nano"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-03-768507","article-title":"CD177 modulates human neutrophil migration through activation-mediated integrin and chemoreceptor regulation","volume":"130","author":"Bai","year":"2017","journal-title":"Blood"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.5A0116-037R","article-title":"Lessons from a double-transgenic neutrophil approach to induce antiproteinase 3 antibody-mediated vasculitis in mice","volume":"100","author":"Schreiber","year":"2016","journal-title":"J Leukoc Biol"},{"key":"B41","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1186\/s12931-020-01401-4","article-title":"CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial","volume":"21","author":"Lazaar","year":"2020","journal-title":"Respir Res"},{"key":"B42","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.pupt.2015.02.001","article-title":"The safety and tolerability of oral AZD5069, a selective CXCR2 antagonist, in patients with moderate-to-severe COPD","volume":"31","author":"Kirsten","year":"2015","journal-title":"Pulm Pharmacol Ther"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1039\/C8CC05496G","article-title":"Turning off bacillus cereus quorum sensing system with peptidic analogs","volume":"54","author":"Yehuda","year":"2018","journal-title":"Chem Commun (Camb)"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-08-1098","article-title":"Synthesis and characterization of a high-affinity {alpha}v{beta}6-specific ligand for in vitro and in vivo applications","volume":"8","author":"Li","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3791\/52933","article-title":"Isolation and characterization of neutrophils with anti-tumor properties","author":"Sionov","year":"2015","journal-title":"J Vis Exp"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-3801-8_3","article-title":"Isolation and characterization of low- vs","volume":"1458","author":"Sagiv","year":"2016","journal-title":"High-Density Neutrophils Cancer Methods Mol Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gky178","article-title":"An upstream open reading frame (uORF) signals for cellular localization of the virulence factor implicated in pregnancy associated malaria","volume":"46","author":"Fastman","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/0005-2736(93)90105-9","article-title":"Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases","volume":"1151","author":"Haran","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"B49","article-title":"Epidermal growth factor receptor (EGFR)-targeted immunoliposomes mediate specific and efficient drug delivery to EGFR- and EGFRvIII-overexpressing tumor cells","volume":"63","author":"Mamot","year":"2003","journal-title":"Cancer Res"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1003871\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,5]],"date-time":"2022-10-05T08:52:12Z","timestamp":1664959932000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2022.1003871\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,5]]},"references-count":49,"alternative-id":["10.3389\/fimmu.2022.1003871"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2022.1003871","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,5]]},"article-number":"1003871"}}